ADIA — Adia Nutrition, Inc.
—
OTC ·
Materials ·
Chemicals ·
CIK 1160420 ·
Last close
$0.16
Market Cap
$15.10M
52W High
$0.24
52W Low
$0.04
ADV30
5,163
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 176,275 | 67,577 | -151,920 | -162,525 | 776,868 | 136,716 | 1,197,067 |
| Mar 2025 | 71,764 | 14,052 | -110,544 | -116,219 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-86,212
Investing CF
$-8,288
Financing CF
$182,964
CapEx
$-8,288
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-21
Balance + Analyst (yfinance extras)
Retained Earnings
$-16,136,007
Inventory
$109,750
Receivables
$79,610
ST Investments
$6,450
EBIT TTM
$-262,089
Pretax Income TTM
$-278,744
Interest Exp TTM
$16,655
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$805,019
EBITDA
$-377,449
Free Cash Flow
—
Enterprise Value
$16,024,495
Total Cash
$136,716
Total Debt
$902,102
Shares Out
94,404,696
Trailing EPS
$0.00
Book Value
$-0.01
ROE
—
ROA
—
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 700,508 | -366,492 | -395,464 | 594,826 | 852,500 | — | -179,228 |
| Dec 2024 | 6,380 | -174,749 | -181,067 | 666,181 | 640,641 | — | -335,476 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CNEY | CN ENERGY GROUP. INC. | $15.29M | $2.02 | — |
| CSDX | CS DIAGNOSTICS CORP. | $15.50M | $0.06 | — |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | $16.00M | $2.55 | — |
| HYEX | HEALTHY EXTRACTS INC. | $16.65M | $1.13 | — |
| BNKK | BONK, INC. | $13.60M | $1.70 | — |
News headlines (Yahoo Finance, 1h cache)
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
2026-05-26 12:00 · Yahoo
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
2026-05-20 15:58 · Yahoo
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
2026-05-15 11:59 · Yahoo
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
2026-05-11 14:04 · Yahoo
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
2026-05-05 14:08 · Yahoo
Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
2026-04-28 12:30 · Yahoo
Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Ye
2026-04-22 12:00 · Yahoo
Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model
2026-04-15 12:30 · Yahoo
Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study
2026-04-08 12:30 · Yahoo
Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status
2026-04-01 14:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.